BlinkLab Limited (BB1), a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism and ADHD. The Company's most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old.
Find out what a historical investment in BlinkLab would be worth today using our BB1 stock calculator.
Buying BB1 shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BlinkLab in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BB1
What is the ticker symbol of BlinkLab?
The ticker symbol for BlinkLab is BB1.
How much is one share of BB1?
One share of BB1 is valued at $0.54 as of 20 November 2026.
What is the market capitalisation of BlinkLab BB1?
As of 20 November 2026 BlinkLab has a market cap of $97.86M.
What is the P/E ratio of BB1?
The Price to Earnings ratio of BB1 is -10.09.
What is the Earnings Per Share of BB1?
The Earnings Per Share of BB1 is -$0.06.
What is the 52-week high for BlinkLab stock?
The BlinkLab 52-week high stock price is $1.11.
What is the 52-week low for BlinkLab stock?
The BlinkLab 52-week low stock price is $0.54.
Can I buy BB1 shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BB1 shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.